A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer
Public ClinicalTrials.gov record NCT03899649. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This multicenter, observational study will evaluate the effectiveness and safety of the NanoKnife System when used for the ablation of Stage 3 pancreatic adenocarcinoma (Stage 3 PC). Eligible patients will be recruited over a 36-month period and participating institutions will enroll and provide data on consecutive patients that meet inclusion and exclusion criteria. Each patient will be followed up for the duration of the study or until death. The study will include two (2) cohorts: patients who received standard of care (SOC) and received irreversible electroporation (IRE) \[IRE cohort\], and patients who were treated with SOC and did not receive IRE \[SOC cohort\].
Study identification
- NCT ID
- NCT03899649
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 532 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 8, 2019 (Actual)
- Primary completion
- Apr 2025 (Estimated)
- Completion
- Apr 2025 (Estimated)
- Last update posted
- Feb 12, 2025
2019 – 2025
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Moores Cancer Center, UC San Diego Health | La Jolla | California | 92093 | — |
| University of Florida Health | Gainesville | Florida | 32608 | — |
| Miami Cancer Institute | Miami | Florida | 33176 | — |
| Wellstar Medical Group | Marietta | Georgia | 30060 | — |
| Northwest Community Hospital | Arlington Heights | Illinois | 60005 | — |
| University of Iowa Healthcare | Iowa City | Iowa | 52242 | — |
| Norton Healthcare | Louisville | Kentucky | 40202 | — |
| Mayo Clinic, Rochester | Rochester | Minnesota | 55905 | — |
| Barnes-Jewish Hospital | St Louis | Missouri | 63110 | — |
| NYU Langone | New York | New York | 10016 | — |
| Presbyterian Hospital, Columbia | New York | New York | 10032 | — |
| Atrium Health | Charlotte | North Carolina | 28204 | — |
| St. Luke's University Health Network | Easton | Pennsylvania | 18045 | — |
| University of Texas-Southwestern | Dallas | Texas | 75231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03899649, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 12, 2025 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03899649 live on ClinicalTrials.gov.